Search Results

• • 32 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Hepatitis C virus RNA in southern African Blacks with hepatocellular carcinoma

  Authors:Jens Bukh, Roger H. Miller, Michael C. Kew, and Robert H. PurcellFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 90, Issue 5) Peer-Reviewed

  Mar. 1, 199368 words Article

   Abstract Only

• Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees

  Authors:Xavier Forns, Robert Thimme, Sugantha Govindarajan, Suzanne U. Emerson, Robert H. Purcell, Francis V. Chisari, et al.From:Proceedings of the National Academy of Sciences of the United States (Vol. 97, Issue 24) Peer-Reviewed

  Nov. 21, 2000161 words Article

   Abstract Only

• Current status of a hepatitis C vaccine: Encouraging results but significant challenges ahead

  Author:Jens BukhFrom:Current Infectious Disease Reports (Vol. 9, Issue 2)

  Mar. 2007169 words Article

   Abstract Only

• Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay

  Authors:Jens Bukh, Robert H. Purcell, and Roger H. MillerFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 89, Issue 1) Peer-Reviewed

  Jan. 1, 199298 words Article

   Abstract Only

• Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1

  Authors:Jean-Christophe Meunier, Ronald E. Engle, Kristina Faulk, Ming Zhao, Birke Bartosch, Harvey Alter, et al.From:Proceedings of the National Academy of Sciences of the United States (Vol. 102, Issue 12) Peer-Reviewed

  Mar. 22, 2005250 words Author abstract

   Abstract Only

• The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences

  Authors:Akito Sakai, Marisa St. Claire, Kristina Faulk, Sugantha Govindarajan, Suzanne U. Emerson, Robert H. Purcell, et al.From:Proceedings of the National Academy of Sciences of the United States (Vol. 100, Issue 20) Peer-Reviewed

  Sept. 30, 2003317 words Author abstract

   Abstract Only

• How Escherichia coli can bias the results of molecular cloning: preferential selection of defective genomes of hepatitis C virus during the cloning procedure

  Authors:Xavier Forns, Jens Bukh, Robert H. Purcell, and Suzanne U. EmersonFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 94, Issue 25) Peer-Reviewed

  Dec. 9, 1997268 words Article

   Abstract Only

• Neutralizing Antibodies in Patients with Chronic Hepatitis C, Genotype 1, against a Panel of Genotype 1 Culture Viruses: Lack of Correlation to Treatment Outcome

  Authors:Jannie Pedersen, Tanja B. Jensen, Thomas H. R. Carlsen, Kristian Schonning, Peer Brehm Christensen, Alex Lund Laursen, et al.From:PLoS ONE (Vol. 8, Issue 5) Peer-Reviewed

  May 7, 20138,560 words Article 1490LThe correlation of neutralizing antibodies to treatment outcome in patients with chronic hepatitis C virus (HCV) infection has not been established. The aim of this study was to determine whether neutralizing antibodies...

• Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

  Authors:Robert Thimme, Jens Bukh, Hans Christian Spangenberg, Stefan Wieland, Janell Pemberton, Carola Steiger, et al.From:Proceedings of the National Academy of Sciences of the United States (Vol. 99, Issue 24) Peer-Reviewed

  Nov. 26, 2002118 words Abstract

   Abstract Only

• Sequence analysis of the 5' noncoding region of hepatitis C virus

  Authors:Jens Bukh, Robert H. Purcell, and Roger H. MillerFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 89, Issue 11) Peer-Reviewed

  June 1, 199277 words Article

   Abstract Only

• A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans

  Authors:John Lok Man Law, Chao Chen, Jason Wong, Darren Hockman, Deanna M. Santer, Sharon E. Frey, et al.From:PLoS ONE (Vol. 8, Issue 3) Peer-Reviewed

  Mar. 19, 20135,129 words Article 1580LAuthor(s): John Lok Man Law 1 , * , Chao Chen 1 , Jason Wong 1 , Darren Hockman 1 , Deanna M. Santer 1 , Sharon E. Frey 2 , Robert B. Belshe 2 , Takaji Wakita 3 , Jens Bukh 4 , Christopher T. Jones 5 , Charles M. Rice 5...

• Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system

  Authors:Yi-Ping Li, Santseharay Ramirez, Sanne B. Jensen, Robert H. Purcell, Judith M. Gottwein, and Jens BukhFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 109, Issue 48) Peer-Reviewed

  Nov. 27, 2012 Author abstract, Rep...

   Citation Only

• MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR

  Authors:Yi-Ping Li, Judith M. Gottwein, Troels K. Scheel, Tanja B. Jensen, and Jens BukhFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 108, Issue 12) Peer-Reviewed

  Mar. 22, 2011265 words Author abstract, Rep...

   Abstract Only

• Functional analyses of GB virus B p13 protein: Development of a recombinant GB virus B hepatitis virus with a p7 protein

  Authors:Shingo Takikawa, Ronald E. Engle, Suzanne U. Emerson, Robert H. Purcell, Marisa St. Claire, and Jens BukhFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 103, Issue 9) Peer-Reviewed

  Feb. 28, 2006241 words Author abstract

   Abstract Only

• Corrections

  Authors:Raymond Tellier, Jens Bukh, and Suzanne U. EmersonFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 94, Issue 19) Peer-Reviewed

  Sept. 16, 1997 Correction notice

   Citation Only

• HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice

  Authors:Jannick Prentoe, Lieven Verhoye, Rodrigo Velazquez Moctezuma, Caroline Buysschaert, Ali Farhoudi, Richard Wang, et al.From:Gut (Vol. 65, Issue 12) Peer-Reviewed

  Dec. 2016 Article

   Citation Only

• Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens.

  Authors:Jannick Prentoe, Christoph M. Janitzek, Rodrigo Velázquez-Moctezuma, Louise Goksøyr, Rebecca W. Olsen, Margherita Fanalista, et al.From:PLoS ONE (Vol. 16, Issue 7) Peer-Reviewed

  July 30, 20219,226 words Report 1570LYearly, about 1.5 million people become chronically infected with hepatitis C virus (HCV) and for the 71 million with chronic HCV infection about 400,000 die from related morbidities, including liver cirrhosis and...

• Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee

  Authors:Masayuki Yanagi, Robert H. Purcell, Suzanne U. Emerson, and Jens BukhFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 94, Issue 16) Peer-Reviewed

  Aug. 5, 1997205 words Article

   Abstract Only

• In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes

  Authors:Birke Bartosch, Jens Bukh, Jean-Christophe Meunier, Christelle Granier, Ronald E. Engle, William C. Blackwelder, et al.From:Proceedings of the National Academy of Sciences of the United States (Vol. 100, Issue 24) Peer-Reviewed

  Nov. 25, 2003208 words Author abstract

   Abstract Only

• At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide

  Authors:Jens Bukh, Robert H. Purcell, and Roger H. MillerFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 90, Issue 17) Peer-Reviewed

  Sept. 1, 199389 words Article

   Abstract Only